4.8 Article

Cas9-mediated targeting of viral RNA in eukaryotic cells

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1422340112

关键词

Cas9; CRISPR-Cas; hepatitis C virus; RNA targeting; Francisella

资金

  1. National Institutes of Health (NIH) [R01-AI11070, U54-AI057157]
  2. Burroughs Wellcome Fund
  3. Yerkes Research Center Base Grant [P51RR-000165]
  4. NIH [R01-AI070101, R01-DK083356]
  5. National Science Foundation Graduate Research Fellowship Program
  6. Achievement Rewards for College Scientists Foundation

向作者/读者索取更多资源

Clustered, regularly interspaced, short palindromic repeats-CRISPR associated (CRISPR-Cas) systems are prokaryotic RNA-directed endonuclease machineries that act as an adaptive immune system against foreign genetic elements. Using small CRISPR RNAs that provide specificity, Cas proteins recognize and degrade nucleic acids. Our previous work demonstrated that the Cas9 endonuclease from Francisella novicida (FnCas9) is capable of targeting endogenous bacterial RNA. Here, we show that FnCas9 can be directed by an engineered RNA-targeting guide RNA to target and inhibit a human +ssRNA virus, hepatitis C virus, within eukaryotic cells. This work reveals a versatile and portable RNA-targeting system that can effectively function in eukaryotic cells and be programmed as an antiviral defense.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据